Profil bibliographique

Nasser Harouna

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

11Publications signalées

23Citations signalées

0Affiliations récentes

Domaines associés

Global Maternal and Child HealthChild Nutrition and Water AccessPneumonia and Respiratory InfectionsAntibiotic Use and ResistanceNeonatal and Maternal Infections

Publications récentes

Accès ouvert 2026 articleOpenAlex

Azithromycin mass drug administration to reduce child mortality in Niger (AVENIR II): a master protocol for a cluster-randomized adaptive platform trial to evaluate community-based health interventions

Ahmed M. Arzika, Abdou Amza, Sani Ousmane, Ramatou Maliki et autres

1 citationTrials

Accès ouvert 2026 otherOpenAlex

Azithromycin mass drug administration to reduce child mortality in Niger (AVENIR II): a master protocol for a cluster-randomized adaptive platform trial to evaluate community-based health interventions

Ahmed M. Arzika, Abdou Amza, Sani Ousmane, Ramatou Maliki et autres

0 citationsFigshare

Accès ouvert 2026 articleOpenAlex

Additional file 1 of Azithromycin mass drug administration to reduce child mortality in Niger (AVENIR II): a master protocol for a cluster-randomized adaptive platform trial to evaluate community-based health interventions

Ahmed M. Arzika, Abdou Amza, Sani Ousmane, Ramatou Maliki et autres

0 citationsFigshare

Accès ouvert 2026 articleOpenAlex

Additional file 1 of Azithromycin mass drug administration to reduce child mortality in Niger (AVENIR II): a master protocol for a cluster-randomized adaptive platform trial to evaluate community-based health interventions

Ahmed M. Arzika, Abdou Amza, Sani Ousmane, Ramatou Maliki et autres

0 citationsFigshare

Accès ouvert 2026 otherOpenAlex

Azithromycin mass drug administration to reduce child mortality in Niger (AVENIR II): a master protocol for a cluster-randomized adaptive platform trial to evaluate community-based health interventions

Ahmed M. Arzika, Abdou Amza, Sani Ousmane, Ramatou Maliki et autres

0 citationsFigshare

Accès ouvert 2025 articleOpenAlex

Impact of biannual azithromycin on weight-for-age z-score among infants in the AVENIR cluster-randomised trial

Brittany F. Peterson, Ahmed M. Arzika, Ramatou Maliki, Amza Abdou et autres

0 citationsBMJ Paediatrics Open

Accès ouvert 2025 articleOpenAlex

Spillover of Azithromycin Mass Drug Administration and Child Survival

Ahmed M. Arzika, Abdou Amza, Ramatou Maliki, Bawa Aichatou et autres

8 citationsJAMA Network Open

Accès ouvert 2025 preprintOpenAlex

Azithromycin mass drug administration to reduce child mortality in Niger (AVENIR II): a master protocol for a cluster-randomized adaptive platform trial to evaluate community-based health interventions

Ahmed M. Arzika, Abdou Amza, Sani Ousmane, Ramatou Maliki et autres

0 citationsmedRxiv

Accès ouvert 2025 articleOpenAlex

Seasonality of underweight among infants 1–11 months old in Niger: an exploratory analysis of data from a cluster-randomised trial

Brittany F. Peterson, Ahmed M. Arzika, Ramatou Maliki, Amza Abdou et autres

1 citationBMJ Global Health

Accès ouvert 2025 articleOpenAlex

Mass distribution of azithromycin and child mortality among underweight infants in rural Niger: a subgroup analysis of the AVENIR cluster-randomised trial

Brittany F. Peterson, Ahmed M. Arzika, Ramatou Maliki, Amza Abdou et autres

2 citationsBMJ Open

Accès ouvert 2023 articleOpenAlex

Distance to Health Centers and Effectiveness of Azithromycin Mass Administration for Children in Niger

Dennis L. Chao, Ahmed M. Arzika, Amza Abdou, Ramatou Maliki et autres

11 citationsJAMA Network Open

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.